Table 1.

Effects of dopamine agonists bromoscriptine and cabergoline on metabolic abnormalities in patients with hyperprolactinemia.

	Bromocriptine	Cabergoline
Body weight	↓	↓
BMI	↓	↓
Fasting glucose	↓	↓
Fasting insulin	↓	↓
Insulin sensitivity	↑	↑
Insulin resistance	↓	↓
Prevalence of metabolic syndrome	↓	↓

Arrows indicate the increase or the decrees of metabolic parameters.